Harnessing Microbial Therapeutics to Prime Immunity & Expand Cancer Treatment Possibilities

2:30 pm - Thursday 29th January 2026

  • Explore IO Prime as a strategy to enhance immune readiness and improve response to existing therapies
  • Demonstrate how trained immunity and microbial reprogramming can unlock new combination approaches in oncology
  • Understand the rationale behind an upcoming trial using attenuated oral salmonella

Speakers:

Chief Scientific Officer
Prokarium